USPTO serial 87545864
DIVERTEX
Reviewed by CopyMark Law Group
Reg. 5620106Status 710
- Filing date
- Status date
- Registration date
- Dec 4, 2018
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DIVERTEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John E. Lyhus
John E. Lyhus FITCH, EVEN, TABIN & FLANNERY LLP120 SOUTH LASALLE STREETSUITE 2100CHICAGO, IL 60603Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Ophthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santen Pharmaceutical Co., Ltd.
- Other trademarks owned by Santen Pharmaceutical Co., Ltd.
- Other trademarks owned by Santen Pharmaceutical Co., Ltd.
- Other trademarks in Class 010
- Similar marks named DIVERTEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 20, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 4, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 18, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 18, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 18, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 18, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 1, 2018 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Nov 1, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 9, 2018 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 9, 2018 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Oct 9, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 11, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 4, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 4, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 4, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 11, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 25, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 31, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 31, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 31, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2017 | NWAP | NEW APPLICATION ENTERED | — |